drugset / Trial / NCT00501345
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Primary Objective: To determine the risk of bleeding from ASA therapy in thrombocytopenic patients who develop Acute Coronary Syndrome (ACS), and assess its effect on the overall morbidity and mortality in these patients as well as platelet functions.
Timeline
- Start
- 2002-02
- Primary completion
- 2008-02
- Completion
- 2008-02
Outcome
Outcome not reported
Stopped (Enrollment): “Low accrual, study terminated.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 160 mg | Oral |